Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL2202761 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL5613815 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL28214952 | 1.00 | — | — | |
| Bicarbonate SCHEMBL5553271 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL904704 | 1.00 | — | — | |
| Bicarbonate SCHEMBL904554 | 1.00 | — | — | |
| Bicarbonate SCHEMBL7124048 | 0.94 | — | — | |
| Bicarbonate SCHEMBL5557762 | 0.94 | — | — | |
| Bicarbonate SCHEMBL14563606 | 0.94 | — | — | |
| Bicarbonate SCHEMBL81418 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6645535-B2 | Gastrointestinal disorders | WM. WRIGLEY JR. COMPANY | 2003-11-11 | — | — | US | claimed |
| WO-2002051259-A1 | COATED CHEWING GUM PRODUCTS CONTAINING VARIOUS ANTACIDS | WM. WRIGLEY JR. COMPANY (US) | 2002-07-04 | — | — | WO | claimed |
| US-20010021403-A1 | Coated chewing gum products containing various antacids | WM. WRIGLEY JR. COMPANY | 2001-09-13 | — | — | US | claimed |
| US-20080153880-A1 | PAN-ALPHA-2 RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | ALLERGAN, INC. | 2008-06-26 | — | — | US | disclosed |
| US-20080153881-A1 | ALPHA-2B RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS | ALLERGAN, INC. | 2008-06-26 | — | — | US | disclosed |
| US-20070239104-A1 | Anti acid G/tube pad | FEERRAR ANGELA C | 2007-10-11 | — | — | US | disclosed |
| US-6645535-B2 | Gastrointestinal disorders | WM. WRIGLEY JR. COMPANY | 2003-11-11 | — | — | US | disclosed |
| WO-2002051259-A1 | COATED CHEWING GUM PRODUCTS CONTAINING VARIOUS ANTACIDS | WM. WRIGLEY JR. COMPANY (US) | 2002-07-04 | — | — | WO | disclosed |
| US-20010021403-A1 | Coated chewing gum products containing various antacids | WM. WRIGLEY JR. COMPANY | 2001-09-13 | — | — | US | disclosed |
| US-4539195-A | ANTACIDES | GIULINI CHEMIE GMBH (DE) | 1985-09-03 | — | — | US | disclosed |